We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NRP:JSENEPI Rockcastle N.V Analysis

Data as of 2026-03-11 - not real-time

ZAC 13,676.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

NEPI Rockcastle is trading at 13,676 ZAc, well below its 20‑day (14,597), 50‑day (14,633) and 200‑day (14,161) moving averages, indicating a short‑term price weakness. Technical indicators reinforce the oversold condition – the RSI sits at 26.4 and the MACD histogram remains negative, though volume is on the rise, suggesting buying interest may be building. Fundamentally, the company looks cheap with a trailing P/E of 10.3 versus an industry average of 32.6, while delivering robust margins (gross 69%, operating 62%, profit 54%) and 9.3% revenue growth YoY. The dividend yield is attractive at 7.9% with a payout ratio of roughly 80%, supported by solid operating cash flow of ZAc 453 m and free cash flow of ZAc 237 m. However, leverage is notable – total debt of ZAc 3.1 bn dwarfs cash of ZAc 0.31 bn, giving a debt‑to‑equity of 62%, which tempers the upside. The DCF model points to a fair value of about 295 ZAc per share, implying roughly 18% upside to the current price, and the market sentiment is in “Extreme Greed” territory, adding a momentum boost.
Given the low beta of 0.18 and a 30‑day volatility of 16%, price swings are modest, and the stock sits on a clear support level at 13,333 ZAc with resistance near 15,450 ZAc. The combination of an undervalued valuation relative to peers, high dividend yield, and strong cash generation makes the stock a compelling candidate for investors seeking income and value, while the elevated debt and geopolitical exposure in Central‑Eastern Europe warrant a cautious watch.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Oversold technicals (RSI 26, price below all SMAs)
  • Attractive dividend yield of 7.9% with strong cash flow
  • DCF upside of ~18% despite current weakness

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Stable earnings growth and high profit margins
  • Elevated leverage requiring monitoring
  • Price positioned between clear support and resistance levels

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Consistent revenue growth and robust cash generation
  • Low beta and moderate volatility offering defensive characteristics
  • Sustained high dividend yield with reasonable payout ratio

Key Metrics & Analysis

Financial Health

Revenue Growth9.30%
Profit Margin53.60%
P/E Ratio10.3
ROE10.06%
ROA4.06%
Debt/Equity62.04
P/B Ratio102.3
Op. Cash FlowZAC453.5M
Free Cash FlowZAC237.0M
Industry P/E32.6

Technical Analysis

TrendNeutral
RSI26.4
SupportZAC 13,333.00
ResistanceZAC 15,450.00
MA 20ZAC 14,596.80
MA 50ZAC 14,632.74
MA 200ZAC 14,160.70
MACDBearish
VolumeIncreasing
Fear & Greed Index76.86

Valuation

Fair ValueZAC 295.33
Target PriceZAC 16,104.79
Upside/Downside17.76%
GradeUndervalued
TypeBlend
Dividend Yield7.87%

Risk Assessment

Beta0.18
Volatility16.25%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.